Partnering Event! October 28th 2015 in Helsinki, Finland We invite you to discover one of Finland’s largest and most innovative projects within life sciences! 3iRegeneration: • A large strategic research opening at the University of Helsinki and Aalto University • Received a record 11,9 Million € and runs from 2014-2018 • Nine expert principal investigators commercially supported by Helsinki Innovation Services • Multiple areas of commercial interest including stem cell therapy and regenerative compounds, drug delivery systems and microchips • We are now seeking collaborations, partnerships and further investment We seek business opportunities in: • Small molecules inducing stem cell differentiation and reprogramming of somatic cells • Targeted and controlled drug delivery systems utilizing nanoparticles • Miniaturized mass spectrometry-based technologies and services • Biomarker diagnostics Contact Project leader heikki.ruskoaho@helsinki.fi Scientific coordinator virpi.talman@helsinki.fi Business coordinator amanda.coniel@helsinki.fi Register now at: www.3iregeneration.com Program Location: Scandic Park Hotel, Mannerheimintie 46, 00260, Helsinki • 8.30 – 9.00 Breakfast and Coffee • 9.00- 9.10 Tekes Welcome - Dr. Ilona Lundström • 9.10 – 9.20 3iR Introduction - Prof. Heikki Ruskoaho • 9.20 – 11.05 • • • • • • 3i Stem Cells:Revolutionary progress in stem cell and genome editing technologies – Prof. Timo Otonkoski 3i Analytics: Development of analytical technologies and microchips Prof. Tapio Kotiaho 3i Medicinal Chemistry: From design to synthesis - Prof. Jari YliKauhaluoma 3i Nano: Targeting into the Heart: Nanomedicines for Heart Diseases - Dr. Helder Santos 3i Neuro: Towards drug-induced brain regeneration - Prof. Raimo Tuominen 3i Heart: How to mend a broken heart - Prof. Heikki Ruskoaho • 11.05 – 11.20 Coffee Break • 11.20 – 11.40 Drug research and development program at the University of Helsinki - Prof. Raimo Tuominen • 11.40 – 11.50 The Finnish Academic Pharma Innovation Hub - Amanda Coniel • 11.50 – 12.30 Panel Discussion: Drug development needs in Finland and bridging the gap between academia and pharma - Reijo Salonen (Orion Pharma), Jukka Westermarck (Turku Centre for Biotechnology), Christer Strömberg (Bayer), Heikki Ruskoaho (Helsinki University, Faculty of Pharmacy) and Antti Vuolanto (Targovax/Oncos Therapeutics) • 12.30 – 13.30 Lunch & Networking • 13.30 – 15.30 Networking continued (you can also request to meet with one or more of the 3i groups during this session)